Immunopathways in giant cell arteritis and polymyalgia rheumatica.
about
Aspirin as adjunctive treatment for giant cell arteritisAspirin as adjunctive treatment for giant cell arteritisThe role of biological agents in the management of large vessel vasculitis (LVV): a systematic review and meta-analysisStatin use in giant cell arteritis: a retrospective study.Cancer preceding giant cell arteritis: a case-control studyPolymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.Vascular damage in giant cell arteritis.[Medium and large vessel vasculitis].Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis.Varicella zoster virus vasculopathy: analysis of virus-infected arteries.Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis.Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis.Vascular dendritic cells in giant cell arteritis.T cells in arteritis and atherosclerosis.Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases.Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis.Vasculitis: an update.Recent advances in polymyalgia rheumatica.Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.Calprotectin in rheumatic diseases.An unusual case of aortic rupture after deployment of a bare stent in the treatment of aortic dissection in a patient with giant-cell arteritis.Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis.Giant cell arteritis: dendritic cells take two T's to tango.Polymyalgia rheumatica and the risk of stroke: a three-year follow-up study.Stroke associated with giant cell arteritis: a population-based study.
P2860
Q24194497-4F354996-FE20-426D-B44D-4B8F203BF1CDQ24198176-7908A868-D026-46F8-B6DB-1C9D761E9919Q26853258-ACCDF2CC-079A-4274-9E10-70C7A7FAB319Q33576127-A64522B8-3206-4D9F-9482-EE55DEAB617FQ34012677-4D9D8571-C6BF-471B-BEE3-D29A0D883C2CQ34205665-99AA0073-0258-433D-9443-8795DCC8EDD0Q34743236-7D16FF27-EBDF-4267-9180-13508F1ADB3EQ34976638-F8BAE34D-EB9D-41E7-9718-44518FBF23E7Q35102137-2F9F6CB1-6056-44C7-93DF-41ADB9066742Q35119607-56EB807D-B026-4816-92CF-77248CE6AE6DQ35637008-5E005143-4EE1-42B3-BAC1-C82A3E710651Q36138118-3856B3A3-8C9C-4696-A72B-1536401274F8Q36388695-74F2649B-88DA-49A7-B953-E66814C18D37Q37192834-D7671CEA-FBDE-4855-8370-AF649B4D9006Q37289670-7128D9FD-5C5D-4A01-BFBA-FD9D5DD03D7FQ37421806-89377C71-AA48-411C-A048-491683E4B657Q38238796-694C7DBF-5C50-441B-9A46-F0B4A6B13D78Q38513257-FE652B99-2424-41F9-B630-46815D454BCEQ38588648-8D7FF92F-AE7E-47CC-AD74-7E46C2CB98BCQ39022858-DA7BA9B0-5ECD-4476-A5CB-C8531821C7AEQ40964246-D06B026D-583D-4134-A81C-17D8C9938F16Q41141307-1CC565F1-83C0-4711-AD10-6BEB31DC8C85Q42917861-0376565C-2E0A-4B28-94B2-35C056E42F7FQ43722950-437DD11F-6080-4951-813C-5223C84DC6E3Q44736294-EBE7174C-AC67-4550-9D2B-C511A428B683
P2860
Immunopathways in giant cell arteritis and polymyalgia rheumatica.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immunopathways in giant cell arteritis and polymyalgia rheumatica.
@ast
Immunopathways in giant cell arteritis and polymyalgia rheumatica.
@en
type
label
Immunopathways in giant cell arteritis and polymyalgia rheumatica.
@ast
Immunopathways in giant cell arteritis and polymyalgia rheumatica.
@en
prefLabel
Immunopathways in giant cell arteritis and polymyalgia rheumatica.
@ast
Immunopathways in giant cell arteritis and polymyalgia rheumatica.
@en
P2093
P1433
P1476
Immunopathways in giant cell arteritis and polymyalgia rheumatica.
@en
P2093
Cornelia M Weyand
Jörg J Goronzy
Wei Ma-Krupa
P356
10.1016/S1568-9972(03)00064-8
P577
2004-01-01T00:00:00Z